• Vidarabine Monohydrate: Mechanistic Insights and Advanced Pr

  2026-04-20

  Discover the molecular mechanisms and advanced assay protocols of Vidarabine monohydrate, a high-purity nucleoside analog for antiviral research. This article offers original analysis on optimizing its use and bridging cutting-edge findings to practical lab workflows.

• Phebestin as a Nanomolar Aminopeptidase Inhibitor in Malaria

  2026-04-19

  This study introduces phebestin, a bestatin-related aminopeptidase inhibitor, as a potent antiplasmodial agent with nanomolar efficacy against both chloroquine-sensitive and -resistant Plasmodium falciparum strains. The findings suggest that targeting parasite aminopeptidases remains a viable strategy to overcome malaria drug resistance and inform future therapeutic development.

• PR-619: Deubiquitylating Enzymes Inhibitor for Pathway Resea

  2026-04-18

  PR-619 stands out as a broad-spectrum, cell-permeable deubiquitylating enzymes inhibitor, enabling precise dissection of ubiquitination and autophagic pathways. Its reversible, non-proteasomal inhibition profile unlocks advanced applications in cancer biology and neurodegenerative disease models, with robust protocols and troubleshooting strategies for reproducible results.

• Acridine Orange hydrochloride: Technical Guide for Nucleic A

  2026-04-17

  Acridine Orange hydrochloride (SKU B7747) provides rapid, differential fluorescence-based staining of DNA and RNA in cytochemical workflows, supporting cell cycle analysis and apoptosis research where precise discrimination of nucleic acid species is required. It is not optimized for long-term solution storage or for applications demanding in vivo stability beyond immediate analytical timepoints.

• Fucoidan: Workflow Optimization for Anticancer and Immune As

  2026-04-16

  Explore how high-purity Fucoidan empowers apoptosis, angiogenesis inhibition, and immune modulation in cancer and virology research. This guide delivers stepwise protocols, troubleshooting insights, and cross-domain innovations for reproducible, data-driven results with APExBIO’s sulfated α-L-Fucan.

• LEE011 Succinate: Precision CDK Inhibition in Cancer Researc

  2026-04-15

  Ribociclib succinate (LEE011 succinate) empowers cancer research with robust, selective CDK4/6 inhibition, driving reproducible cell cycle arrest and synergistic combination regimens. This guide details data-driven workflows, advanced troubleshooting, and actionable insights for maximizing assay reliability and translational relevance.

• Fenipentol (1-Phenylpentan-1-ol): Benchmarks in Pancreatobil

  2026-04-14

  Fenipentol (1-Phenylpentan-1-ol) is a bioactive small molecule extracted from Ligusticum chuanxiong, known for modulating pancreatobiliary secretion and estrogen receptor α activity. Its quantitative effects in gastrointestinal physiology and historical use as a choleretic agent are supported by peer-reviewed and supplier data. This dossier details mechanistic, safety, and workflow parameters for advanced research applications.

• MCC950 Sodium: Optimizing Endothelial Pyroptosis Assays for

  2026-04-13

  Explore how MCC950 sodium empowers precise investigation of NLRP3-driven endothelial pyroptosis in inflammatory disease research. This article offers advanced assay guidance and practical insights distinct from existing protocols, grounded in recent mechanistic discoveries.

• Butylated Hydroxyanisole (BHA): Precision Antioxidant for Ox

  2026-04-12

  Butylated hydroxyanisole (BHA) by APExBIO offers a reproducible, high-purity solution for probing oxidative stress, modulating apoptosis pathways, and advancing inflammation research. From robust ROS detection to workflow optimization, BHA empowers biomedical scientists with validated parameters and troubleshooting insights for sensitive cellular assays.

• Gut Microbiota Modulation and Neuroinflammation in Chronic H

  2026-04-12

  This study used [18F]PBR146 PET imaging to assess the impacts of Bifidobacterium and fecal microbiota transplantation (FMT) on neuroinflammation in a rat model of chronic hepatic encephalopathy. The findings highlight Bifidobacterium's ability to suppress neuroinflammation, whereas FMT did not confer similar benefits, emphasizing the need to understand microbiota-specific effects in gut–liver–brain axis interventions.

• MCC950 Sodium: Precision NLRP3 Inflammasome Inhibition in Re

  2026-04-11

  Discover how MCC950 sodium (CRID3 sodium salt) empowers researchers to dissect NLRP3-driven inflammation in cell and animal models with unparalleled selectivity. This guide translates recent endothelial cell findings into actionable workflows, troubleshooting, and protocol optimization for inflammatory and autoimmune disease research.

• SB 431542: ALK5 Inhibitor Workflows for Organogenesis Models

  2026-04-11

  SB 431542 enables precise TGF-β pathway modulation in advanced organoid and immunology assays. This guide translates the latest reference innovations and expert troubleshooting into actionable, reproducible workflows for stem cell and cancer research.

• Ertapenem Sodium Salt: Advanced Workflows for Resistance ...

  2026-04-10

  Ertapenem (sodium salt) empowers researchers with a robust, broad-spectrum carbapenem antibiotic for dissecting bacterial resistance, especially in complex multidrug-resistant contexts. Leveraging APExBIO’s high-purity formulation, scientists can streamline susceptibility testing, resistance gene transmission studies, and quantitative pharmacokinetics, achieving reliable, reproducible results even with challenging Gram-negative and Gram-positive isolates.

• Vorinostat (SAHA, MK0683): Optimizing Apoptosis and Epige...

  2026-04-09

  This article delivers scenario-driven, evidence-based guidance for using Vorinostat (SAHA, MK0683) (SKU A4084) in cell viability, apoptosis, and epigenetic modulation workflows. Bench researchers will find actionable data, real-world troubleshooting, and vendor comparison, highlighting how APExBIO's formulation ensures reproducibility and interpretability in advanced oncology studies.

• Puromycin Aminonucleoside: Gold-Standard Podocyte Injury ...

  2026-04-08

  Puromycin aminonucleoside is the benchmark nephrotoxic agent for inducing precise podocyte injury and glomerular lesions, enabling advanced modeling of nephrotic syndrome and FSGS. Its robust solubility, reproducibility, and mechanistic clarity make it indispensable for both in vivo and in vitro renal pathology research.

406 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page